tiprankstipranks
eHealth, Inc. Reports Mixed Q3 2024 Results
Company Announcements

eHealth, Inc. Reports Mixed Q3 2024 Results

Ehealth ( (EHTH) ) has released its Q3 earnings. Here is a breakdown of the information Ehealth presented to its investors.

Pick the best stocks and maximize your portfolio:

eHealth, Inc., a prominent online health insurance marketplace, operates primarily in the insurance sector, offering access to a wide array of health insurers. In its latest earnings report, eHealth highlighted its robust performance in the Medicare segment, despite a decrease in overall revenue. The company reported a 22% increase in Medicare submissions and a 6% rise in total Medicare approved members compared to the previous year. However, total revenue for the third quarter of 2024 decreased by 10% year-over-year, primarily due to a decline in positive net adjustment revenue.

Key financial metrics revealed that while eHealth’s total revenue excluding net adjustment revenue grew by 9%, the GAAP net loss increased by 15% to $42.5 million. The company made strategic advancements, including extending its term loan at improved rates and successfully gearing up for the Annual Enrollment Period (AEP) with a strong agent workforce and enhanced online platform capabilities.

The decline in acquisition costs per Medicare Advantage approved member by 16% signals efficient cost management. Additionally, eHealth’s adjusted EBITDA, excluding net adjustment revenue, showed a positive trend, improving by $4.3 million year-over-year. Despite the challenges, the company maintains a solid cash position with $117.8 million in cash, cash equivalents, and marketable securities.

Looking ahead, eHealth, Inc. remains optimistic about future growth, maintaining its full-year guidance with expectations of 15% growth in non-GAAP total revenue, excluding net adjustment revenue. The company is poised to leverage its strategic initiatives to enhance profitability and expand its member base in the forthcoming enrollment periods.

Related Articles
TheFlyPfizer provides FY25 outlook, McCormick in talks for Sauer Brands: Morning Buzz
TipRanks Auto-Generated NewsdeskeHealth Boosts 2024 Outlook Following Strong AEP Performance
TheFlyeHealth raises 2024 revenue view to $500M-$520M from $470M-$494M
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App